We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.7B
AUM Growth
+$3.07B
Cap. Flow
+$921M
Cap. Flow %
2.32%
Top 10 Hldgs %
13.97%
Holding
792
New
111
Increased
260
Reduced
279
Closed
96

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$212M
2
ABT icon
Abbott
ABT
+$143M
3
MS icon
Morgan Stanley
MS
+$138M
4
ITW icon
Illinois Tool Works
ITW
+$135M
5
GE icon
GE Aerospace
GE
+$114M

Sector Composition

Rank Sector Weight
1 Healthcare 14.15%
2 Technology 13.4%
3 Financials 12.89%
4 Industrials 11.08%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLR icon
626
Fluor
FLR
$6.54B
$4.3M 0.01%
81,818
-122,900
-60% -$6.7M
HII icon
627
Huntington Ingalls Industries
HII
$11B
$4M 0.01%
20,000
-31,504
-61% -$6.4M
ICLR icon
628
Icon
ICLR
$13.7B
$3.99M 0.01%
50,000
ULTA icon
629
Ulta Beauty
ULTA
$21.8B
$3.96M 0.01%
13,900
-71,200
-84% -$19.5M
OXY icon
630
Occidental Petroleum
OXY
$55.7B
$3.89M 0.01%
61,400
-10,800
-15% -$718K
MANT
631
DELISTED
Mantech International Corp
MANT
$3.82M 0.01%
110,226
+79,263
+256% +$3.02M
EXPD icon
632
Expeditors International
EXPD
$22.3B
$3.75M 0.01%
66,303
-3,700
-5% -$203K
JNPR
633
DELISTED
Juniper Networks
JNPR
$3.74M 0.01%
134,300
-1,187,900
-90% -$33.1M
ATRA icon
634
Atara Biotherapeutics
ATRA
$72.6M
$3.68M 0.01%
7,160
CIE
635
DELISTED
Cobalt International Energy, Inc
CIE
$3.64M 0.01%
455,293
+60,000
+15% +$725K
RRC icon
636
Range Resources
RRC
$9.33B
$3.62M 0.01%
+124,274
New +$3.84M
WNR
637
DELISTED
Western Refining Inc
WNR
$3.51M 0.01%
100,000
NVO
638
Novo Nordisk
NVO
$228B
$3.43M 0.01%
+200,000
New +$3.48M
XNCR icon
639
Xencor
XNCR
$1.45B
$3.21M 0.01%
+134,000
New +$3.23M
AMRN
640
Amarin Corp
AMRN
$297M
$3.2M 0.01%
+50,000
New +$3.17M
AZN icon
641
AstraZeneca
AZN
$269B
$3.11M 0.01%
50,000
-244,366
-83% -$14.2M
NVET
642
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$3.09M 0.01%
795,000
SNR
643
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$3.06M 0.01%
300,000
RARX
644
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3M 0.01%
141,000
-34,000
-19% -$650K
WFM
645
DELISTED
Whole Foods Market Inc
WFM
$2.92M 0.01%
98,215
-59,185
-38% -$1.78M
AYI icon
646
Acuity Brands
AYI
$9.99B
$2.9M 0.01%
14,193
-258,896
-95% -$54.7M
CRIS icon
647
Curis
CRIS
$9.71M
$2.89M 0.01%
520
+2
+0.4% +$11.1K
NPKI
648
NPK International
NPKI
$1.02B
$2.83M 0.01%
350,000
NVRO
649
DELISTED
NEVRO CORP.
NVRO
$2.81M 0.01%
+30,000
New +$2.72M
LUMN icon
650
Lumen
LUMN
$6.43B
$2.78M 0.01%
117,966
-668,456
-85% -$16.3M

Similar funds

Adage Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Adage Capital Partners held 792 positions worth $39.7B, up 8.4% from $36.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Adage Capital Partners's Q1 2017 filing shows 111 new, 260 increased, 279 reduced and 96 closed positions. Its largest new stake was American Express: 1,192,300 shares worth $94.3M. The largest sale was St Jude Medical, an estimated $276M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Adage Capital Partners's largest Q1 2017 buy was American Express: 1,192,300 shares worth $94.3M.
  • Adage Capital Partners added most to Deere & Co in Q1 2017, an estimated $212M increase.
  • Adage Capital Partners's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $225M.
  • Adage Capital Partners fully exited St Jude Medical in Q1 2017, selling an estimated $276M.
  • Adage Capital Partners's ten largest holdings make up 14% of its $39.7B portfolio in Q1 2017.
  • Adage Capital Partners opened 111 new positions and closed 96 in Q1 2017.
  • Adage Capital Partners's portfolio value rose 8.4% quarter-over-quarter to $39.7B.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.